Disease Markers / 2018 / Article / Tab 3

Research Article

ABCC4 Variants Modify Susceptibility to Kawasaki Disease in a Southern Chinese Population

Table 3

Stratification analysis of susceptibility in Kawasaki disease patients.

VariablesCombined effect of risk genotypes (patients/controls) valueaOR (95% CI) valueAdjusted OR (95% CI) valueb

Age, months
<12163/16222/150.28181.46 (0.73–2.91)0.28541.46 (0.73–2.91)0.2855
12–60475/51652/340.02531.66 (1.06–2.61)0.02701.65 (1.05–2.59)0.0296
>6053/4410/30.11552.77 (0.72–10.68)0.13973.52 (0.87–14.33)0.0790
Male477/48847/370.25101.30 (0.83–2.04)0.25261.31 (0.84–2.06)0.2378
Female214/23437/150.00122.70 (1.44–5.05)0.00202.69 (1.43–5.03)0.0021
Coronary artery outcomes
CAA91/72212/520.09041.83 (0.94–3.56)0.07441.84 (0.94–3.60)0.0748
CAL170/72217/520.27271.39 (0.78–2.46)0.26091.39 (0.78–2.47)0.2619
NCAL430/72255/520.00471.78 (1.19–2.64)0.00461.77 (1.18–2.63)0.0053

aχ2 test for genotype distributions between Kawasaki disease patients and controls; badjusted for age and gender.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.